V H J van der Velden - JoVE Visualize

Showing results (1-10 of 59) with videos related to

Pageof 6

Sort By:

Journal of Biological Regulators and Homeostatic Agents|October 9, 2004

Detection of minimal residual disease in acute leukemiaV H J van der Velden, N Boeckx, E R van Wering, et al.

Leukemia|May 24, 2003

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsV H J van der Velden, A Hochhaus, G Cazzaniga, et al.

Leukemia|July 3, 2002

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysisV H J van der Velden, J M Wijkhuijs, D C H Jacobs, et al.

Leukemia|August 6, 2004

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotypingM Malec, V H J van der Velden, E Björklund, et al.

Leukemia|March 16, 2002

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemiaN Boeckx, M J Willemse, T Szczepanski, et al.

Leukemia|March 19, 2004

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patientsV H J van der Velden, N Boeckx, I Jedema, et al.

Leukemia|May 3, 2002

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCRV H J van der Velden, M J Willemse, C E van der Schoot, et al.

Cytometry. Part B, Clinical Cytometry|June 29, 2004

Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shiftsE G van Lochem, V H J van der Velden, H K Wind, et al.

Leukemia|November 14, 2003

Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacityI Jedema, R M Y Barge, V H J van der Velden, et al.

Leukemia|October 25, 2003

Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALLT Szczepański, V H J van der Velden, T Raff, et al.

Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:

Pageof 6

Journal of Biological Regulators and Homeostatic Agents|October 9, 2004

Detection of minimal residual disease in acute leukemiaV H J van der Velden, N Boeckx, E R van Wering, et al.

Leukemia|May 24, 2003

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsV H J van der Velden, A Hochhaus, G Cazzaniga, et al.

Leukemia|July 3, 2002

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysisV H J van der Velden, J M Wijkhuijs, D C H Jacobs, et al.

Leukemia|August 6, 2004

Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotypingM Malec, V H J van der Velden, E Björklund, et al.

Leukemia|March 16, 2002

Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemiaN Boeckx, M J Willemse, T Szczepanski, et al.

Leukemia|March 19, 2004

High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patientsV H J van der Velden, N Boeckx, I Jedema, et al.

Leukemia|May 3, 2002

Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCRV H J van der Velden, M J Willemse, C E van der Schoot, et al.

Cytometry. Part B, Clinical Cytometry|June 29, 2004

Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shiftsE G van Lochem, V H J van der Velden, H K Wind, et al.

Leukemia|November 14, 2003

Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacityI Jedema, R M Y Barge, V H J van der Velden, et al.

Leukemia|October 25, 2003

Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALLT Szczepański, V H J van der Velden, T Raff, et al.

Pageof 6